press-events/
35 pages · Updated July 25, 2026
Pages
- VeriSIM Life Founder & CEO Dr. Jo Varshney Named to Inc.’s Female Founders 500 for Advancing Predictive Drug Development │ Drug Discovery & Development Technology
- VeriSIM Life Wins Gold for Most Innovative Company of the Year in Annual Stevie® Awards for Women in Business │ Drug Discovery & Development Technology
- VeriSIM Life Named Finalist for Reuters AI in Action Award Category │ Drug Discovery & Development Technology
- VeriSIM Life Launches AtlasGEN™ Novel Drug Designer │ Drug Discovery & Development Technology
- VeriSIM Life Named Finalist for the 2025 Scrip Awards Innovation Category │ Drug Discovery & Development Technology
- VeriSIM Life launches PulmoSIM Therapeutics to Develop Treatments for Rare Respiratory Diseases │ Drug Discovery & Development Technology
- VeriSIM Life Wins Prestigious AI in Action Award at Reuters Global Pharma Awards │ Drug Discovery & Development Technology
- VeriSIM Life Named Most Innovative Company Finalist in Stevie® Awards for Women in Business │ Drug Discovery & Development Technology
- VeriSIM Life Secures $15 Million Series A Funding │ Drug Discovery & Development Technology
- VeriSIM Life Partners with Clarivate to Help Researchers Accelerate and De-Risk Drug Development │ Drug Discovery & Development Technology
- VeriSIM Life Wins “Machine Learning Platform of the Year” at the 2025 AI Breakthrough Awards │ Drug Discovery & Development Technology
- VeriSIM Life Wins "Best AI-Driven Drug Development Engine 2025 - USA" in GHP Biotechnology & Lifesciences Awards │ Drug Discovery & Development Technology
- VeriSIM Life successfully raises $5.2m USD to avoid unnecessary drug testing in animals during drug development │ Drug Discovery & Development Technology
- VeriSIM Life Secures a Federal Grant to Create a Drug Combinatorial Platform Against COVID-19 │ Drug Discovery & Development Technology
- VeriSIM Life Founder & CEO Dr. Jo Varshney Named to 2025 "100 Women in AI" List │ Drug Discovery & Development Technology
- VeriSIM Life Formalizes Research Collaboration with FDA/NCTR, Advancing the Next Generation of Mechanistic AI for Drug Development │ Drug Discovery & Development Technology
- VeriSIM Life Named "Predictive Analytics Solution of the Year" at BioTech Breakthrough Awards for Second Consecutive Year │ Drug Discovery & Development Technology
- VeriSIM Life Earns Frost & Sullivan Competitive Strategy Leadership Award for Best Practices in AI-enabled Preclinical Development Industry │ Drug Discovery & Development Technology
- VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders │ Drug Discovery & Development Technology
- VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTech Breakthrough │ Drug Discovery & Development Technology
- VeriSIM CEO Jo Varshney Selected Finalist for 2023 Stevie® Awards for Women in Business │ Drug Discovery & Development Technology
- VeriSIM Life Earns "Predictive Analytics Solution of the Year" Recognition by BioTech Breakthrough Awards for Third Consecutive Year │ Drug Discovery & Development Technology
- Jo Varshney, Founder and CEO of VeriSIM Life, Wins Gold in Annual Stevie® Awards for Women in Business │ Drug Discovery & Development Technology
- VeriSIM Life Awarded Federal Grant from National Institutes of Health for Substance Use Disorder Drug Discovery and Development │ Drug Discovery & Development Technology
- VeriSIM Life Announces Collaboration with Mayo Clinic to Accelerate New Drug Development │ Drug Discovery & Development Technology
- VeriSIM Life Announces Acquisition of Molomics Biotech │ Drug Discovery & Development Technology
- VeriSIM Life Awarded NIH Phase II STTR to Advance AI Driven Drug Discovery Platform │ Drug Discovery & Development Technology
- VeriSIM Life Announces Webinar on Mitigating Translational Risk in Drug Development with AI/ML │ Drug Discovery & Development Technology
- Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development │ Drug Discovery & Development Technology
- VeriSIM Press & Events │ Drug Discovery & Development Technology
- Dr. Varshney Selected as Finalist for Executive Leader Award in Women in AI Awards North America 2025 │ Drug Discovery & Development Technology
- Dr. Jo Varshney Named to List of Most Influential Women in Bay Area Business from the San Francisco Business Times │ Drug Discovery & Development Technology
- VeriSIM Life CEO Dr. Jo Varshney Wins Prestigious 2025 International Women Entrepreneur Award in Information Technology │ Drug Discovery & Development Technology
- Five AI-enhanced clinical trial start-ups to watch in 2021 │ Drug Discovery & Development Technology
- VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs │ Drug Discovery & Development Technology